Sector Update: Health Care Stocks Mixed Premarket Friday
9:14AM ET 7/01/2022 MT NewswiresHealth care stocks were mixed premarket Friday. The Health Care SPDR (XLV) was 0.28% lower, and the iShares NASDAQ Biotechnology Index (IBB) was recently...
Cytokinetics Prices $450 Million Private Placement of Convertible Notes; Doubles Development Loan
4:00AM ET 7/01/2022 MT NewswiresCytokinetics (CYTK) said Friday it has priced a private placement of $450 million principal amount of 3.5% convertible senior notes due 2027. Initial...
Sector Update: Health Care Stocks Swoon Late, Closing Lower
4:06PM ET 6/30/2022 MT NewswiresHealth care stocks slipped fully below the surface this afternoon, with the NYSE Health Care Index falling 0.2% and the SPDR Health Care Select Sector ETF...
Sector Update: Health Care Stocks Little Changed on Thursday
1:59PM ET 6/30/2022 MT NewswiresHealth care stocks were narrowly mixed this afternoon, with the NYSE Health Care Index sliding 0.1% while the SPDR Health Care Select Sector ETF (XLV) was...
Update: Cytokinetics Proposes Private Offering of $450 Million Convertible Senior Notes -- Shares Sink in Pre-Market Trading
7:06AM ET 6/30/2022 MT Newswires(Updates with the stock move in the headline and the first paragraph.) Cytokinetics (CYTK) shares slumped more than 17% in the most recent pre-market...
Update: Cytokinetics Proposes Private Offering of $450 Million Convertible Senior Notes -- Shares Sink in Late Hours
5:22PM ET 6/29/2022 MT Newswires(Updates with the stock move in the headline and first paragraph.) Cytokinetics (CYTK) shares slumped more than 14% in late-hours trading after the company...
Cytokinetics Proposes Private Offering of $450 Million Convertible Senior Notes
4:46PM ET 6/29/2022 MT NewswiresCytokinetics (CYTK) said Wednesday it proposed a private offering of $450 million of convertible senior notes due 2027. The company expects to grant the...
Cytokinetics Says FDA Advisory Committee to Meet in December to Review NDA for Heart Disease Drug
8:08AM ET 6/24/2022 MT NewswiresCytokinetics (CYTK) said Friday the US Food and Drug Administration's cardiovascular and renal drugs advisory committee will meet on Dec. 13 to review its...
Insider Sell: Cytokinetics
4:31PM ET 6/17/2022 MT NewswiresRobert I Blum, Director, President & CEO, on June 15, 2022, sold 10,000 shares in Cytokinetics (CYTK) for $394,000. Following the Form 4 filing with the...
Cytokinetics Says Prescription Drug User Fee Act Date for Heart Failure Treatment Application Extended by Three Months
9:29AM ET 6/17/2022 MT NewswiresCytokinetics (CYTK) said Friday the US Food and Drug Administration has extended the Prescription Drug User Fee Act date for the company's new drug...